Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06325150
Other study ID # STUDY00008572
Secondary ID
Status Recruiting
Phase Phase 1
First received
Last updated
Start date May 16, 2024
Est. completion date February 1, 2028

Study information

Verified date May 2024
Source Michigan State University
Contact Hanne M Hoffmann, PhD
Phone 517 353 1415
Email hanne@msu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Humans are constantly exposed to a variety of light types, created naturally or through artificial means. Light exposure captured by the eyes impacts many physiological functions in humans, including but not limited to cognitive output, fatigue levels, and mood regulation. The level of impact on cognitive learning from different types of light on undergraduate adult students remains unclear.


Description:

This study has chosen to test light's impact on adult (18 years and older) undergraduate students' cognitive function. We hypothesize that students who wear light-enriched Type1 glasses (bright light emitting glasses) for one session (20 minutes) will experience greater cognitive function, than those who either wear light-enriched Type 2 glasses(placebo light) or no glasses at all. This study will answer the following questions: 1. After a single session (20 minutes) of wearing light-enriched glasses, on average how much did the students' cognitive function increase as compared to students without light-enriched glasses? 2. Does cognitive function increase to a comparable degree using both types of light-enriched glasses for a single session (20 minutes)? 3. Does the time of day impact the effects of light-enriched glasses during a single session (20 minutes), thus improve cognitive function? 4. Does time of day impact cognitive function for students who do not participate in light-enriched testing? The study will gather additional data variables on the following questions: 5. After wearing either type of light-enriched glasses, did the student's fatigue decrease throughout the study? How does this data compare to those who did not take part in light glasses testing? 6. After wearing either type of light-enriched glasses, did the student's mood increase throughout the study? How does this data compare to those who did not take part in light glasses testing? 7. How does the compiled data from the questionnaires and tests compare to sleep data collected from Smart Watches? Objectives: - Data points from participants will be captured through the following questionnaires and testing methods: 1. Consent Form (~ 4 min) 2. Student Questionnaire (~ 2 min) [Demographics] 3. Chronotype Questionnaire, Morningness - Eveningness Self-Assessment * (~ 4 min)[This document tells you if you are an early bird or a night owl.] 4. Pittsburgh Sleep Questionnaire* (~ 2 min) [This document tells you your sleep quality.] 5. PHQ-9 Test * (~ 2 min) [This document assesses your mood.] 6. PROMIS Fatigue Score Test [Measures your current fatigue levels.] 7. Trail Making Test [Measures your cognitive function.] - Additional data variables will be obtained from sleep data captured on personal Smart Watches by participants in the study. In the Student Questionnaire, participants are asked if they would be willing and able to provide the research team with their personal sleep data, covering a time period of two weeks prior to the study and three weeks during the study. This will enable researchers to compare Smart Watch data with fatigue scores and the Sleep Quality Index (Pittsburgh Sleep Questionnaire). - Prior to testing, light composition readings will be taken from numerous locations within the classrooms and outdoors. Light readings will be obtained through a Spectral Light Meter. These readings will allow the researchers to control for ambient light exposure prior to the testing of the light emitting glasses.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date February 1, 2028
Est. primary completion date February 1, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria for wearing light glasses: - Current Michigan State University (MSU) Undergraduate Student - Are 18 years or older - Healthy subject without light sensitivity - Average bedtime 9:30 pm - 2:00 am, 6 out of 7 days a week - Willingness to measure and report fatigue levels - Willingness to participate in cognitive testing - Willingness to wear light-enriched glasses in the classroom Inclusion criteria for the control group (will not wear light glasses): - Current Michigan State University (MSU) Undergraduate Student - Are 18 years or older - Average bedtime 9:30 pm - 2:00 am, 6 out of 7 days a week - Willingness to measure and report fatigue levels - Willingness to participate in cognitive testing Inclusion criteria for the control group (will not wear light glasses): - Current Michigan State University (MSU) Undergraduate Student - Are 18 years or older - Average bedtime 9:30 pm - 2:00 am, 6 out of 7 days a week - Willingness to measure and report fatigue levels - Willingness to participate in cognitive testing Exclusion criteria for wearing light glasses: - Are younger than 18 years of age - Participation in shift work (evening/night shifts, early morning shifts, rotating shifts, etc.) - Pregnant women - Previous diagnosis of diabetes - Use of medication that would cause sensitivity to light (e.g., antidepressants, antibiotics,prescribed sleep medication, prescribed pain meds) - Epilepsy or a history of seizures - Photophobia - sensitivity or eye discomfort to bright light - Eye Diseases that limit the ability of light to be processed (e.g., untreated cataracts,severe glaucoma, macular degeneration, blindness, pupil dilation problems, or retinadamage) - Previous eye surgery - Previous head injuries (e.g., concussions) - Current chronic, severe headaches/migraines - Clinical insomniacs or those with diagnosed sleep disorders

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Light emitting glasses
Assess the capacity of 20 min use of AYO light emitting glasses on different outcomes

Locations

Country Name City State
United States Michigan State University East Lansing Michigan

Sponsors (1)

Lead Sponsor Collaborator
Michigan State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of attention To measure the impact of the intervention on attention, for each student we will measure the time it takes for the student to complete the provided test, and the number of errors in the test. Each student will completed the test, before and after the intervention, and the change in test score (time and errors) calculated. 3 weeks. One test per week
Secondary Determine how time of day impacts attention To determine how time of day impacts attention, we will reanalyze the data from "Outcome 1", and control for the time of day the students participated in the study. We will measure the time it took to complete the test, as well as the number of errors in the test. 3 weeks. One test per week
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1